Cytek® Biosciences Deepens Commitment to Flow Cytometry
Cytek Biosciences has launched a two-part initiative with the International Society for Advancement of Cytometry to expand access to...
No videos found.
BridgeBio Reports Q3 2025 Financial Results & Updates
BridgeBio reported third-quarter revenue of $120.7 million, anchored by $108.1 million in U.S. net product sales from Attruby (acoramidis)...
Argenx Data Shows Remarkable VYVGART Benefit for MG Patients
Argenx presented a sweep of new Vyvgart data at AANEM/MGFA 2025, headlined by the phase 3 ADAPT SERON trial...
Ianalumab Reduces Sjögren’s Disease Activity in Phase III
Novartis reported positive Phase 3 results for ianalumab in Sjögren’s disease, with the 300 mg monthly subcutaneous regimen meeting...
New Hope: Rosnilimab Trial Shows Positive Arthritis Results
AnaptysBio reported late-breaking results from its 424-patient Phase 2b RA study showing that rosnilimab, a selective pathogenic T cell...
Achieve Life Sciences Sets Q3 Financial Results Call Nov 6
Achieve Life Sciences will report third-quarter results on November 6 and deliver a corporate update on cytisinicline, its late-stage...
Silo Pharma Selects T12 Fund for New Solana RWA Investment
Silo Pharma has moved a portion of its corporate treasury into the AlphaLedger/Simplify Target 12% Distribution Fund on the...
Paris Hilton Shares The Truth About Her ADHD Journey, Treatment
Collegium Pharmaceutical has launched a high-profile awareness collaboration with Paris Hilton centered on adult ADHD, with plans for Hilton...
Medicus & GSA Collaboration Offers Hope for Gorlin Syndrome
Medicus Pharma has entered a strategic collaboration with the Gorlin Syndrome Alliance to pursue an Expanded Access IND for...
Kamada to Present at the Stifel 2025 Healthcare Conference
Kamada will brief investors at the Stifel 2025 Healthcare Conference in New York on November 12 at 9:20 a.m....